U.S. Limb Prosthetics Market by Type (Upper Limb Prosthetics and Lower Limb Prosthetics), by Technology (Conventional Prosthetic Devices, Electric Prosthetic Devices, and Hybrid Prosthetic Devices), by Component (Socket, Appendage, Joint, Connecting Module, and Others), by End-user (Orthotist & Prosthetist (O&P), Forecast 2024-2032
The U.S. Limb Prosthetics Marketsize was valued at USD 738.5 USD Million in 2023 and is projected to reach USD 1095.85 USD Million by 2032, exhibiting a CAGR of 5.8 % during the forecast period.Limb prosthetics are inferior artificial limbs that substitute for those that are missing. This technology serves to provide mobility and functionality to individuals with limb loss. Such prosthetics are equipped with the different functions to meet specific needs; examples include variations of socket types for comfort, development of lightweight materials for easy use, and use of sensors to enhance control and responsiveness. Among the various limb prosthetics varieties, there are basically three forms – body-powered, passive and myoelectric prosthetics. The first two are essentially cosmetic, and the last is response driven. The utilisation of the invention is not limited to physical disabilities alone the applications cut across several field such as helping amputees in their day to day tasks and even giving athletes the opportunity to compete at high levels. Recent technologies in the making have begun new age alterations of limb prosthetics, in the forms of 3D printing enabling customized designs, AI-based systems for better functioning and implants for a smooth connection with the body. This being so, technology is always advancing, making available different types of prosthetics for persons with limb loss that can improve their independence and quality of life.
January 2023: WillowWood Global LLC formed a strategic alliance with Reboocon Bionics B.V. to focus on outcomes research, exclusive U.S. market distribution, and R&D collaboration to promote the next generation of the technology.
December 2022: NYU Langone Health completed its first set of surgeries by using the U.S. Food and Drug Administration (FDA)-approved implantable prosthetic. The device is for people with limb loss and is available in greater New York City.
October 2020: Proteor USA signed an agreement with Ottobock to acquire a significant portion of Freedom Innovations' lower limb prosthetics portfolio.
The comprehensive report provides an in-depth analysis of the U.S. limb prosthetics market, including:
Aspects | Details |
---|---|
Study Period | 2018-2032 |
Base Year | 2023 |
Estimated Year | 2024 |
Forecast Period | 2024-2032 |
Historical Period | 2018-2023 |
Growth Rate | CAGR of 5.8% from 2018-2032 |
Segmentation |
|
Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014
Craig Francis
Business Development Head
+44 1223 92 666
sales@advancemarketanalytics.com
get latest updates and offers.